LLY

981.02

-0.38%↓

JNJ

241.78

+0.08%↑

ABBV

220.91

+0.56%↑

NVS

154.19

+0.72%↑

AZN

191.67

+0.82%↑

LLY

981.02

-0.38%↓

JNJ

241.78

+0.08%↑

ABBV

220.91

+0.56%↑

NVS

154.19

+0.72%↑

AZN

191.67

+0.82%↑

LLY

981.02

-0.38%↓

JNJ

241.78

+0.08%↑

ABBV

220.91

+0.56%↑

NVS

154.19

+0.72%↑

AZN

191.67

+0.82%↑

LLY

981.02

-0.38%↓

JNJ

241.78

+0.08%↑

ABBV

220.91

+0.56%↑

NVS

154.19

+0.72%↑

AZN

191.67

+0.82%↑

LLY

981.02

-0.38%↓

JNJ

241.78

+0.08%↑

ABBV

220.91

+0.56%↑

NVS

154.19

+0.72%↑

AZN

191.67

+0.82%↑

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Open

5.02

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.91

Max

5.03

Schlüsselkennzahlen
By Trading Economics
Einkommen	410K -4.2M
Gewinnspanne	-6,655.714
Angestellte	26

Dividenden
By Dow Jones
Nächstes Ergebnis	19. März 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	18M 38M
Vorheriger Eröffnungskurs	5.02
Vorheriger Schlusskurs	5.02

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. März 2026, 21:14 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15. März 2026, 21:14 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16. März 2026, 00:00 UTC

Wichtige Nachrichtenereignisse

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15. März 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15. März 2026, 23:44 UTC

Market Talk

Wichtige Nachrichtenereignisse

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15. März 2026, 23:35 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15. März 2026, 23:00 UTC

Akquisitionen, Fusionen, Übernahmen

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15. März 2026, 22:37 UTC

Market Talk

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15. März 2026, 22:18 UTC

Market Talk

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15. März 2026, 22:14 UTC

Ergebnisse

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15. März 2026, 22:14 UTC

Ergebnisse

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15. März 2026, 22:14 UTC

Ergebnisse

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15. März 2026, 22:14 UTC

Ergebnisse

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15. März 2026, 22:14 UTC

Ergebnisse

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15. März 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15. März 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15. März 2026, 03:00 UTC

Wichtige Nachrichtenereignisse

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14. März 2026, 15:00 UTC

Wichtige Nachrichtenereignisse

Iran War Delivers Windfall to America's Oil Country -- WSJ

14. März 2026, 02:03 UTC

Ergebnisse

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14. März 2026, 01:32 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14. März 2026, 00:29 UTC

Akquisitionen, Fusionen, Übernahmen

13D Filings -- Barrons.com

13. März 2026, 22:27 UTC

Market Talk

Wichtige Nachrichtenereignisse

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13. März 2026, 22:13 UTC

Market Talk

Wichtige Nachrichtenereignisse

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13. März 2026, 22:04 UTC

Market Talk

Wichtige Nachrichtenereignisse

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13. März 2026, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13. März 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13. März 2026, 20:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

Financial Services Roundup: Market Talk

13. März 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13. März 2026, 19:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13. März 2026, 19:35 UTC

Wichtige Nachrichtenereignisse

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.